Showing results (31-40 of 122) with videos related to
Sort By:
Pageof 13
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2026
Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65-69 Years (CAREMM-2110 study)Jung Yeon Lee, Seungpil Jung, Sung-Soo Park, et al.British Journal of Haematology|November 17, 2019
Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R-CHOPYoung-Woo Jeon, Joo-Hyun O, Kyung-Sin Park, et al.Diagnostics (Basel, Switzerland)|January 25, 2025
The Role of Small Bowel Capsule Endoscopy in Determining the Treatment Strategy for Duodenal Follicular Lymphoma: A Single-Center Retrospective StudyDonghoon Kang, Gi-June Min, Tong Yoon Kim, et al.Annals of Hematology|February 25, 2023
Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experienceGi-June Min, Donghoon Kang, Han Hee Lee, et al.International Journal of Hematology|December 1, 2017
Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two casesNayoun Kim, Hyun-Jung Sohn, Joo Hyun Oh, et al.Diagnostics (Basel, Switzerland)|September 9, 2023
Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell LymphomaWoo Hee Choi, Eun Ji Han, Joo Hyun O, et al.Journal of Cancer Research and Clinical Oncology|June 20, 2014
The BRAF mutation is associated with the prognosis in colorectal cancerTae Sung Ahn, Dongjun Jeong, Myoung Won Son, et al.EJNMMI Research|November 23, 2019
Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomasHye Lim Park, Joo Hyun O, Sonya Youngju Park, et al.Plos One|September 25, 2020
Mantle cell lymphoma with gastrointestinal involvement and the role of endoscopic examinationsHan Hee Lee, Seok-Goo Cho, In Seok Lee, et al.Blood Research|April 7, 2023
Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible multiple myeloma: multicenter studyJa Min Byun, Sung-Soo Park, Sung-Soo Yoon, et al.Pageof 13